The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Rise In Market Size Of The Open-Angle Glaucoma (OAG) Market During The Forecast Period?
The open-angle glaucoma (oag) market size has demonstrated robust expansion in recent times. It is anticipated to expand from $6.53 billion in 2025 to $6.96 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.5%. The growth observed during the preceding period can be traced to challenges in accessing in-person mental health services, an increasing prevalence of anxiety and depression, heightened awareness regarding the significance of mental health, the rising adoption of early telemedicine platforms, and the initial integration of online counseling programs.
The market size for open-angle glaucoma (oag) is projected to experience significant growth in the upcoming years. It is expected to expand to $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period can be attributed to factors such as the increasing demand for accessible online therapy, the wider adoption of mobile and web-based counseling tools, the expanding integration of AI-powered mental wellness solutions, the growing utilization of hybrid therapy models that combine individual and group sessions, and the increased availability of online therapy offerings in both commercial and residential sectors. Prominent trends for this period include the rising adoption of prostaglandin analog drugs, an increase in the use of minimally invasive glaucoma surgeries, heightened awareness regarding early diagnosis and screening, an uptick in teleophthalmology consultations for oag management, and the accelerated development of combination drug therapies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp
What Core Drivers Are Transforming The Open-Angle Glaucoma (OAG) Market?
Increasing recognition of eye conditions is anticipated to fuel the expansion of the open-angle glaucoma (OAG) market in the future. Eye conditions encompass medical issues affecting the eyes’ structure, function, or sight, varying from minor problems like dry eye to severe ailments such as glaucoma and macular degeneration. The incidence of these conditions is increasing, attributed to factors such as an aging demographic, extended periods of screen use, a rise in diabetes diagnoses, environmental pollutants, and lifestyle choices detrimental to ocular health. Open-angle glaucoma (OAG), a primary contributor to blindness, particularly in older individuals, highlights the vital importance of regular eye examinations, prompt diagnosis, and active treatment to prevent permanent loss of vision. As an illustration, data from October 2023, supplied by the Royal National Institute of Blind People (RNIB), a UK sight loss charity, indicated that eye care outpatient appointments in the UK surpassed eight million in 2021/22, positioning it as the most sought-after medical specialty. Furthermore, the population experiencing sight loss, currently exceeding two million, is forecast to double to more than four million by 2050. Consequently, heightened awareness regarding eye conditions is propelling expansion within the open-angle glaucoma (OAG) market.
How Is The Open-Angle Glaucoma (OAG) Market Examined Through Segment Analysis?
The open-angle glaucoma (oag) market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types
2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma
Which Trends Are Influencing The Expansion Of The Open-Angle Glaucoma (OAG) Market?
Leading companies in the onychomycosis treatment market are prioritizing the development of new products, such as MOB-015, and securing their approval from federal agencies to achieve a competitive advantage. An illustration of this is Moberg Pharma AB, a pharmaceutical company based in Sweden, which obtained approval for MOB-015 in the European Union in June 2023. This approval is for the treatment of mild to moderate fungal infections of the nails in adults. This European Union endorsement signifies the first global marketing authorization for this innovative onychomycosis medication. The approval of MOB-015 was substantiated by two Phase 3 trials, which demonstrated an enhanced mycological cure rate of 76% versus up to 42% for comparators, alongside a considerably higher total cure rate than the vehicle, all without any serious adverse effects. The topical terbinafine formulation MOB-015 enables effective concentrations of terbinafine to reach the nail and nail bed without the systemic exposure risks associated with oral terbinafine treatment.
Which Organizations Are Operating Within The Open-Angle Glaucoma (OAG) Market?
Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.
Access The Complete Open-Angle Glaucoma (OAG) Market Report:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report
Which Region Contributes The Most To The Open-Angle Glaucoma (OAG) Market?
North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Open-Angle Glaucoma (OAG) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp
Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company
Onychomycosis Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report
Yeast Infection Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report
Aspergillosis Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model